Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mars Stone

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
JCI Insight|March 2, 2023
COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune responseJohn F McDyer, Mahzad Azimpouran, Valerie L Durkalski-Mauldin, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infectionAshok K Dwivedi, David A Siegel, Cassandra Thanh, et al.
Journal of Clinical Microbiology|May 26, 2018
Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV IsolatesMars Stone, John Bainbridge, Ana M Sanchez, et al.
The Journal of Infectious Diseases|March 4, 2025
Viral and Immune Factors Associated With COVID-19 Outcome in the C3PO Trial of Convalescent PlasmaClara Di Germanio, Erika G Marques de Menezes, Robert Clevenger, et al.
Msphere|August 25, 2021
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma TreatmentLiang Chen, Michael C Zody, Clara Di Germanio, et al.
Journal of Clinical Microbiology|November 18, 2025
Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapySonia Bakkour Coco, Mars Stone, Xutao Deng, et al.
Transfusion|May 24, 2022
How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?Rebecca V Fink, Lois Fisher, Hasan Sulaeman, et al.
Cell Reports. Medicine|January 26, 2021
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronavirusesJason T Ladner, Sierra N Henson, Annalee S Boyle, et al.
Journal of Clinical Microbiology|June 4, 2025
Improved HIV-1 RNA detection using whole blood versus plasma in antiretroviral-treated individualsVivian I Avelino-Silva, Mars Stone, Leilani Montalvo, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A population-scale Red Blood Cell proteome atlas of 13,000 donors uncovers genetically encoded aging clocks predicting hemolysis, transfusion efficacy, and donor activity a decade laterMonika Dzieciatkowska, Aaron V Issaian, Gregory R Keele, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
JCI Insight|March 2, 2023
COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune responseJohn F McDyer, Mahzad Azimpouran, Valerie L Durkalski-Mauldin, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infectionAshok K Dwivedi, David A Siegel, Cassandra Thanh, et al.
Journal of Clinical Microbiology|May 26, 2018
Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV IsolatesMars Stone, John Bainbridge, Ana M Sanchez, et al.
The Journal of Infectious Diseases|March 4, 2025
Viral and Immune Factors Associated With COVID-19 Outcome in the C3PO Trial of Convalescent PlasmaClara Di Germanio, Erika G Marques de Menezes, Robert Clevenger, et al.
Msphere|August 25, 2021
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma TreatmentLiang Chen, Michael C Zody, Clara Di Germanio, et al.
Journal of Clinical Microbiology|November 18, 2025
Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapySonia Bakkour Coco, Mars Stone, Xutao Deng, et al.
Transfusion|May 24, 2022
How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?Rebecca V Fink, Lois Fisher, Hasan Sulaeman, et al.
Cell Reports. Medicine|January 26, 2021
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronavirusesJason T Ladner, Sierra N Henson, Annalee S Boyle, et al.
Journal of Clinical Microbiology|June 4, 2025
Improved HIV-1 RNA detection using whole blood versus plasma in antiretroviral-treated individualsVivian I Avelino-Silva, Mars Stone, Leilani Montalvo, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A population-scale Red Blood Cell proteome atlas of 13,000 donors uncovers genetically encoded aging clocks predicting hemolysis, transfusion efficacy, and donor activity a decade laterMonika Dzieciatkowska, Aaron V Issaian, Gregory R Keele, et al.
Pageof 17